Abstract:Space flight poses certain health risks to astronauts, including exposure to space radiation, with protons accounting for more than 80% of deep-space radiation. Proton radiation is also now being used with increasing frequency in the clinical setting to treat cancer. For these reasons, there is an urgent need to better understand the biological effects of proton radiation on the body. Such improved understanding could also lead to more accurate assessment of the potential health risks of proton radiation, as w… Show more
“…We observed depletion of HSCs 3 months after exposure, as well as decreased repopulation capacity of the remaining stem cells in a competitive transplant assay. Previously, elevated levels of reactive oxygen species correlating with decreased HSCs have been observed at 22 weeks after exposure to proton radiation, in line with our observations here . Added mutational load, which is known to occur with MMR defects and radiation exposure , however, did not exacerbate the latent phenotype, at least regarding HSC function.…”
One of the major health concerns on long‐duration space missions will be radiation exposure to the astronauts. Outside the earth's magnetosphere, astronauts will be exposed to galactic cosmic rays (GCR) and solar particle events that are principally composed of protons and He, Ca, O, Ne, Si, Ca, and Fe nuclei. Protons are by far the most common species, but the higher atomic number particles are thought to be more damaging to biological systems. Evaluation and amelioration of risks from GCR exposure will be important for deep space travel. The hematopoietic system is one of the most radiation‐sensitive organ systems, and is highly dependent on functional DNA repair pathways for survival. Recent results from our group have demonstrated an acquired deficiency in mismatch repair (MMR) in human hematopoietic stem cells (HSCs) with age due to functional loss of the MLH1 protein, suggesting an additional risk to astronauts who may have significant numbers of MMR deficient HSCs at the time of space travel. In the present study, we investigated the effects gamma radiation, proton radiation, and 56Fe radiation on HSC function in Mlh1+/+ and Mlh1‐/‐ marrow from mice in a variety of assays and have determined that while cosmic radiation is a major risk to the hematopoietic system, there is no dependence on MMR capacity. stem
cells
translational
medicine
2018;7:513–520
“…We observed depletion of HSCs 3 months after exposure, as well as decreased repopulation capacity of the remaining stem cells in a competitive transplant assay. Previously, elevated levels of reactive oxygen species correlating with decreased HSCs have been observed at 22 weeks after exposure to proton radiation, in line with our observations here . Added mutational load, which is known to occur with MMR defects and radiation exposure , however, did not exacerbate the latent phenotype, at least regarding HSC function.…”
One of the major health concerns on long‐duration space missions will be radiation exposure to the astronauts. Outside the earth's magnetosphere, astronauts will be exposed to galactic cosmic rays (GCR) and solar particle events that are principally composed of protons and He, Ca, O, Ne, Si, Ca, and Fe nuclei. Protons are by far the most common species, but the higher atomic number particles are thought to be more damaging to biological systems. Evaluation and amelioration of risks from GCR exposure will be important for deep space travel. The hematopoietic system is one of the most radiation‐sensitive organ systems, and is highly dependent on functional DNA repair pathways for survival. Recent results from our group have demonstrated an acquired deficiency in mismatch repair (MMR) in human hematopoietic stem cells (HSCs) with age due to functional loss of the MLH1 protein, suggesting an additional risk to astronauts who may have significant numbers of MMR deficient HSCs at the time of space travel. In the present study, we investigated the effects gamma radiation, proton radiation, and 56Fe radiation on HSC function in Mlh1+/+ and Mlh1‐/‐ marrow from mice in a variety of assays and have determined that while cosmic radiation is a major risk to the hematopoietic system, there is no dependence on MMR capacity. stem
cells
translational
medicine
2018;7:513–520
“…Moreover, their results showed that inhibition of NOX4 can protect mice similar to a potent radioprotector (N-acetyl cysteine) [19,20]. Other studies confirmed that continuous ROS production through stimulation of redox interactions plays a key role in the development of both early and late effect of IR [21][22][23]. Weyemi et al showed that inactivation of both NOX4 and NOX5 can mitigate ROS production and oxidative DNA damage in irradiated human fibroblast cells [24].…”
Section: Molecular Mechanisms For Continuous Ros Production Followingmentioning
In this review, we focus on recent findings about natural radioprotectors and mitigators which are clinically applicable for radiotherapy patients, as well as injured people in possible radiation accidents.
“…However, after exposure to high doses of ionizing radiation, cells may undergo massive chromosome damage, depending on cell type . Cells with high mitotic activities may undergo higher levels of DNA damage and cell death, while those with low mitosis activities, have a longer time to repair damaged DNA and show a low incidence of cell death . The production of reactive oxygen species (ROS) by ionizing radiation is responsible for two‐thirds of DNA damage immediately after exposure.…”
Section: Radiation‐induced Injury In Normal Tissuesmentioning
confidence: 99%
“…2,16 Cells with high mitotic activities may undergo higher levels of DNA damage and cell death, while those with low mitosis activities, have a longer time to repair damaged DNA and show a low incidence of cell death. [17][18][19][20] The production of reactive oxygen species (ROS) by ionizing radiation is responsible for two-thirds of DNA damage immediately after exposure. However, studies have revealed that high doses of ionizing radiation may stimulate chronic oxidative stress because of endogenous production of ROS and nitric oxide (NO) by macrophages, lymphocytes, as well as some pro-oxidants, such as nicotinamide adenine dinucleotide phosphate oxidase in other cells.…”
Ionizing radiation plays a central role in several medical and industrial purposes. In spite of the beneficial effects of ionizing radiation, there are some concerns related to accidental exposure that could pose a threat to the lives of exposed people. This issue is also very critical for triage of injured people in a possible terror event or nuclear disaster. The most common side effects of ionizing radiation are experienced in cancer patients who had undergone radiotherapy. For complete eradication of tumors, there is a need for high doses of ionizing radiation. However, these high doses lead to severe toxicities in adjacent organs. Management of normal tissue toxicity may be achieved via modulation of radiation responses in both normal and malignant cells. It has been suggested that treatment of patients with some adjuvant agents may be useful for amelioration of radiation toxicity or sensitization of tumor cells. However, there are always some concerns for possible severe toxicities and protection of tumor cells, which in turn affect radiotherapy outcomes. Selenium is a trace element in the body that has shown potent antioxidant and radioprotective effects for many years. Selenium can potently stimulate antioxidant defense of cells, especially via upregulation of glutathione (GSH) level and glutathione peroxidase activity. Some studies in recent years have shown that selenium is able to mitigate radiation toxicity when administered after exposure. These studies suggest that selenium may be a useful radiomitigator for an accidental radiation event. Molecular and cellular studies have revealed that selenium protects different normal cells against radiation, while it may sensitize tumor cells. These differential effects of selenium have also been revealed in some clinical studies. In the present study, we aimed to review the radiomitigative and radioprotective effects of selenium on normal cells/tissues, as well as its radiosensitive effect on cancer cells.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.